Theracryf Plc (TCF) Ordinary 0.25p

Sell:0.21pBuy:0.23pPrice decreased0.01p (2.22%)

Prices delayed by at least 15 minutes
Sell:0.21p
Buy:0.23p
Change:Price decreased0.01p (2.22%)
Deal now
Prices delayed by at least 15 minutes
Sell:0.21p
Buy:0.23p
Change:Price decreased0.01p (2.22%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open0.23p
Previous close0.23p
Market cap£4.73m
P/E ratio-
Volume5,495,984
Dividend yield0.00%
EMS1000000

Company information

TheraCryf plc is a clinical-stage drug development company focusing on brain disorders. The Company has a clinical and preclinical pipeline of indications, including addiction, anxiety, fatigue, narcolepsy, glioblastoma ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyGBP
  • Shares in issue2.15bn
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.